Diabetes and Hypertension
Advertisement
The prevalence of CKD and cost of screening were the most influential parameters.
A report on outcomes of kidney transplant recipients treated with SGLT2 inhibitors.
The predictive power of ESRD progression was high with choline, myo-inositol, and citrate.
The odds of being prescribed newer second-line diabetes medications decreased with increasing age.
The most common primary renal disease in patients initiating renal replacement therapy is diabetes.
Several classes of glucose-lowering drugs have been shown to have kidney benefits in patients with type 2 diabetes.
The most common concomitant medication classes were antihypertensives (95%), antihyperglycemic (81%), and statins (79%).
Preliminary evidence has demonstrated preservation of kidney function as measured by eGFR compared with baseline.
There was a significant decrease in blood pressure control from 77.6% in 2012 to 74.5% in 2016 and 67.7% in 2020.
Assessing the early impact of risk categorization on management of patients with DKD.
Gaps in care in treating proteinuria in patients with DKD.
Depressive symptoms and adherence to BP goals in SPRINT.
Advertisement
